Clinical Trial Update: Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating petosemtamab in adults with metastatic non-small cell lung cancer, including squamous and non-squamous histologies. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Petosemtamab

Snippet

Sponsor: Merus B.V. | Conditions: Lung Cancer - Non Small Cell Squamous, Lung Cancer - Non Small Cell Non-Squamous | Phase 2 | Status: RECRUITING